跳至主要内容
临床试验/JPRN-UMIN000021822
JPRN-UMIN000021822已完成未知

Study of the effect of the exhale through the nose method by Inhaled corticosteroid and Long Acting Beta2 Agonist (ICS / LABA) combination drug in patients with asthma merger sinusitis - Study of the effect of the exhale through the nose method by ICS / LABA combination drug in patients with asthma merger sinusitis

Department of Otorhinolaryngology Showa University Koto Toyosu Hospital0 个研究点目标入组 12 人开始时间: 2016年5月10日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Those who in this study implementation period is scheduled to surgery for sinusitis 2)A person who has a history that is considered to have an impact on the evaluation of the study (drug abuse, dependence, alcohol abuse, dependence, digestive, heart, liver, lung, eye, blood diseases, etc.) 3)person of corticosteroids, while taking cromolyn sodium (oral oral medicine, nasal drops is not allowed) 4)those who are taking anti-histamines 5)Those who are receiving immunotherapy, including desensitization therapy 6)pregnant women, breast-feeding women 7)current smokers, non smoking duration a person of less than one year 8)Those who can not properly enforce the respiratory function test 9)Other, who is determined to be ineligible as a subject of the present study than test doctor

研究者

发起方
Department of Otorhinolaryngology Showa University Koto Toyosu Hospital

相似试验